In vitro replication phenotype of a novel (−1G) hepatitis B virus variant associated with HIV co‐infection
暂无分享,去创建一个
S. Lewin | C. Thio | P. Revill | N. Warner | S. Locarnini | S. Soppe | D. Colledge | R. Walsh | M. Littlejohn | T. Shaw | V. Sozzi | A. Thompson | L. Cabuang | S. Preiss | N. Lam | G. Matthews | Liza M. Cabuang | Stephen A. Locarnini | Peter A. Revill | Scott Preiss
[1] S. Locarnini,et al. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. , 2011, Journal of hepatology.
[2] P. Revill,et al. The hepatitis B e antigen suppresses IL‐1β‐mediated NF‐κB activation in hepatocytes , 2011, Journal of viral hepatitis.
[3] Suha M. Saleh,et al. Coinfection of Hepatic Cell Lines with Human Immunodeficiency Virus and Hepatitis B Virus Leads to an Increase in Intracellular Hepatitis B Surface Antigen , 2010, Journal of Virology.
[4] P. Revill,et al. Bioinformatic analysis of the hepadnavirus e‐antigen and its precursor identifies remarkable sequence conservation in all orthohepadnaviruses , 2010, Journal of medical virology.
[5] B. McMahon,et al. Chronic hepatitis B: Update 2009 , 2009, Hepatology.
[6] Y. Kondo,et al. A case of HIV co‐infected with hepatitis B virus precore/core deletion mutant treated by entecavir , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.
[7] N. Warner,et al. The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound , 2008, Hepatology.
[8] P. Marcellin,et al. HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa‐2a for HBeAg‐positive chronic hepatitis B , 2008, Hepatology.
[9] S. Lewin,et al. Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals , 2007, AIDS.
[10] R. D. de Man,et al. Future prospectives for the management of chronic hepatitis B. , 2007, World journal of gastroenterology.
[11] S. Lewin,et al. Regulation of Toll‐like receptor‐2 expression in chronic hepatitis B by the precore protein , 2007, Hepatology.
[12] G. Kristiansen,et al. Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. , 2006, Gastroenterology.
[13] Robert Y. L. Wang,et al. Reduced Secretion of Virions and Hepatitis B Virus (HBV) Surface Antigen of a Naturally Occurring HBV Variant Correlates with the Accumulation of the Small S Envelope Protein in the Endoplasmic Reticulum and Golgi Apparatus , 2005, Journal of Virology.
[14] D. Scheuner,et al. The unfolded protein response sensor IRE1alpha is required at 2 distinct steps in B cell lymphopoiesis. , 2005, The Journal of clinical investigation.
[15] D. Lavanchy,et al. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures , 2004, Journal of viral hepatitis.
[16] Chien-Fu Chen,et al. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. , 2003, The American journal of pathology.
[17] H. Isom,et al. Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine‐resistant HBV in vitro , 2003, Hepatology.
[18] S. Sarin,et al. Hepatitis B e‐antigen negative chronic hepatitis B , 2002, Journal of gastroenterology and hepatology.
[19] J. Phair,et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) , 2002, The Lancet.
[20] M. Manns,et al. In Vitro Susceptibilities of Wild-Type or Drug-Resistant Hepatitis B Virus to (−)-β-d-2,6-Diaminopurine Dioxolane and 2′-Fluoro-5-Methyl-β-l-Arabinofuranosyluracil , 2001, Antimicrobial Agents and Chemotherapy.
[21] S. Günther,et al. Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. , 2000, Virology.
[22] Anne Bertolotti,et al. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response , 2000, Nature Cell Biology.
[23] G. Norkrans,et al. HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B. , 1999, Liver.
[24] M. Loriot,et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men , 1999, Hepatology.
[25] M. Manns,et al. A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. , 1997, Gastroenterology.
[26] R. Tedder,et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection , 1997, AIDS.
[27] J. Wands,et al. Posttranscriptional regulation of hepatitis B virus replication by the precore protein , 1997, Journal of virology.
[28] J. Price,et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[29] E. Gelmann,et al. Hepatitis B virus infection in the acquired immunodeficiency syndrome. , 1984, Annals of internal medicine.
[30] M. Skelton,et al. Distinct mutant hepatitis B virus genomes, with alterations in all four open reading frames, in a single South African hepatocellular carcinoma patient. , 2012, Virus research.
[31] Kui Li,et al. The hepatitis B e antigen suppresses IL-1 beta-mediated NF-kappa B activation in hepatocytes , 2011 .
[32] Norman Gitlin,et al. Chronic hepatitis B : an update , 2010 .
[33] M. Manns,et al. In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil. , 2001, Antimicrobial agents and chemotherapy.